Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Eli LillyLargest US-listed GLP-1 franchise via Mounjaro (T2D) and Zepbound (obesity). Retatrutide (triple agonist) in Phase 3; orforglipron (oral non-peptide) expected FDA decision Q2 2026. Also major diabetes, oncology, and immunology portfolios.
All metrics are vertically resized to show how they've changed over time. They're not on the same Y-axis. This chart is meant to compare trends, not values.
Values normalized to 0-100 scale for comparison. Hover for actual values.